|
|
|
Corporate Profile: Altheus Therapeutics
| Summary: |
Altheus Therapeutics is focused on the develoment of therapies for the treatment of inflammatory bowel disease (IBD) with the initial focus on ulcerative colitis (UC).
|
| Address (HQ): |
755 Research Parkway
Suite 435
Oklahoma City, OK 73104 |
| Phone #'s (HQ): |
| Main |
(405) 319-8180 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
